BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 32194509)

  • 1. Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.
    Bielawiec P; Harasim-Symbor E; Chabowski A
    Front Endocrinol (Lausanne); 2020; 11():114. PubMed ID: 32194509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use.
    Blebea NM; Pricopie AI; Vlad RA; Hancu G
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol: State of the art and new challenges for therapeutic applications.
    Pisanti S; Malfitano AM; Ciaglia E; Lamberti A; Ranieri R; Cuomo G; Abate M; Faggiana G; Proto MC; Fiore D; Laezza C; Bifulco M
    Pharmacol Ther; 2017 Jul; 175():133-150. PubMed ID: 28232276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis sativa: Much more beyond Δ
    Alves P; Amaral C; Teixeira N; Correia-da-Silva G
    Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytocannabinoid Pharmacology: Medicinal Properties of
    Sampson PB
    J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
    Nahler G
    Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cavalheiro EKFF; Costa AB; Salla DH; Silva MRD; Mendes TF; Silva LED; Turatti CDR; Bitencourt RM; Rezin GT
    Cannabis Cannabinoid Res; 2022 Apr; 7(2):135-151. PubMed ID: 34242511
    [No Abstract]   [Full Text] [Related]  

  • 9. Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity.
    Bielawiec P; Harasim-Symbor E; Sztolsztener K; Konstantynowicz-Nowicka K; Chabowski A
    Nutrients; 2021 May; 13(5):. PubMed ID: 34064937
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Canseco-Alba A; Rodríguez-Manzo G
    Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
    Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
    J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
    Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
    Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
    Martínez V; Iriondo De-Hond A; Borrelli F; Capasso R; Del Castillo MD; Abalo R
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357565
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
    Kis B; Ifrim FC; Buda V; Avram S; Pavel IZ; Antal D; Paunescu V; Dehelean CA; Ardelean F; Diaconeasa Z; Soica C; Danciu C
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775230
    [No Abstract]   [Full Text] [Related]  

  • 15. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
    Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review.
    Welling MT; Deseo MA; Bacic A; Doblin MS
    Phytochemistry; 2022 Sep; 201():113282. PubMed ID: 35718133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
    Koturbash I; MacKay D
    J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
    Asth L; Iglesias LP; De Oliveira AC; Moraes MFD; Moreira FA
    Epilepsy Behav; 2021 Aug; 121(Pt B):106832. PubMed ID: 31839498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis as a Source of Approved Drugs: A New Look at an Old Problem.
    Gabarin A; Yarmolinsky L; Budovsky A; Khalfin B; Ben-Shabat S
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.